Non-Alcoholic Steatohepatitis (NASH) Market Thumbnail Image

2018

Non-Alcoholic Steatohepatitis (NASH) Market

Non-Alcoholic Steatohepatitis (NASH) Market, by Drug Type (Vitamin E & Pioglitazone, Ocaliva, Elafibranor, and Selonsertib & Cenicriviroc), and Sales Channel (Hospital Pharmacy, Online Provider, and Retail Pharmacy) - Global Opportunity Analysis and Industry Forecast, 2021-2025

LS : Pharmaceuticals

  • Jun 2018

  • Pages: 155

  • Tables: 44

  • Charts: 43

Select an option
Cloud Access (35% Off) $3,456 $2,246
Business User License (35% Off) $5,769 $3,750
Enterprise License (35% Off) $10,995 $7,147
Library Membership (15% Off) $1,175 $999
Request Free Sample
Author's: Pallavi Jaiswal & Sayali Shinde | Roshan Deshmukh
Publish Date:
Update on Demand Speak with Analyst